"Shotgun" versus sequential testing: Cost-effectiveness of diagnostic strategies for vaginitis

Journal of General Internal Medicine

Volumn 20, Issue 9, 2005, Pages 793-799

  Carr, Phyllis L ^a   Rothberg, Michael B ^b,c   Friedman, Robert H ^a   Felsenstein, Donna ^d   Pliskin, Joseph S ^e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cost effectiveness; Decision analysis; Diagnosis; Treatment; Vaginitis

Indexed keywords

ARTICLE; BACTERIUM CULTURE; CHLAMYDIA; COST EFFECTIVENESS ANALYSIS; DNA PROBE; GRAM STAINING; HUMAN; INTERMETHOD COMPARISON; LANGUAGE; NEISSERIA GONORRHOEAE; PH MEASUREMENT; PHYSICAL EXAMINATION; SENSITIVITY ANALYSIS; SEQUENTIAL ANALYSIS; TRICHOMONAS VAGINALIS; VAGINITIS; YEAST;

ADULT; ANTI-INFECTIVE AGENTS; CHLAMYDIA INFECTIONS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; DNA PROBES; FEMALE; HUMANS; HYDROXIDES; METRONIDAZOLE; MONTE CARLO METHOD; POTASSIUM COMPOUNDS; TRICHOMONAS VAGINITIS; UNITED STATES; VAGINITIS; VAGINOSIS, BACTERIAL;

EID: 28444441001     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2005.0188.x     Document Type: Article

References (39)

1. Paavonen J, Stamm WE. Lower genital tract infections in women. Infect Dis Clin North Am. 1987;1:179.
2. Sparks JM. Vaginitis. J Repro Med. 1991;36:745-52.
3. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301.
4. Schaaf VM, Perez-Stable EJ, Borchardt K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med. 1990;150:1929-33.
5. Berg AO, Heidrich FE, Fihn SD, et al. Establishing the cause of genitourinary symptoms in women in a family practice. JAMA. 1984;251: 620-5.
6. Carr PL, Thabault P, Levenson S, Friedman RH. Vaginitis in a community based practice. Clin Res. 1992;40:554A.
7. Bleker OP, Folkertsma K, Dirks-Go SIS. Diagnostic procedures in vaginitis. Eur J Obstet Gynec Reprod Biol. 1989;31:179-83.
8. Eschenbach DA, Hillier SL. Advances in diagnostic testing for vaginitis and cervicitis. J Reprod Med. 1989;34:555-65.
9. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291:1368-79.
10. Sobel JD. Vaginitis in adult women. Obs Gyn Clin N Am. 1990;17: 851-79.
11. Sobel JD. Vaginitis. N Engl J Med. 1997;337:1896-1903.
12. Holmes KK. Lower genital tract infections in women: cystitis/urethritis vulvovaginitis and cervicitis. In Holmes KK, Sparling PF, Mardh P, et al., eds. Sexually Transmitted Diseases. New York: McGraw-Hill; 1999;527-45.
13. Gratton CA, Lim-fong R, Prasad E, Kibsey PC. Comparison of a DNA probe with culture for detecting Chlamydia trachomatis directly from genital specimens. Mol Cell Probes. 1990;4:25-31.
14. Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared ] with conventional clotrimazole topical therapy of Candida vaginitis. Am J Obstet Gynecol. 1995;172:1263-8.
15. Oral fluconazole for vaginal candidiasis. Med Lett. 1994;36:81-2.
16. Reef SE, Levine WC, McNeil MM, et al. Treatment options for vulvo-vaginal candidiasis, 1993. Clin Infec. Dis. 1995;20(suppl 1):S80-90.
17. Clark C, Cooper CL, Gordon SF, et al. A multicenter comparison of one-dose tioconazole ointment with three-dose terconazole cream in vulvo-vaginal candidiasis. J Women' Health. 1993;2:189-96.
18. Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted disease. MMWR. 1993;42:171.
19. Iwen PC, Blair TM, Woods GL. Comparison of the Gen-Probe PACE 2 system, direct fluorescent-antibody, and cell culture for detecting Chlamydia trachomatis in cervical specimens. Am M Clin Pathol. 1991;95: 578-82.
20. Sexually transmitted disease guidelines, CDC. MMWR. 1993;42:171.
21. Bertholf MZ, Stafford MJ. Colonization of Candida albicans in vagina, rectum and mouth. J Fam Pract. 1983;95:919-24.
22. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiological associations. Am J Med. 1983;74:14-22.
23. Krieger JN, Tam MR, Stevens CE, et al. Diagnosis of trichomoniasis: comparison of conventional wet mount preparation with cytological studies, cultures and monoclonal antibody staining of direct specimens. JAMA. 1988;259:1223.
24. Cotch MF, Pasterek JG, Nugent RP, Yerg DE, Martin DH, Eschenbach DA. Demographics and behavioral predictors of Trichomonas vaginitis infection among pregnant women. Obstet Gynecol. 1991;78: 1087-92.
25. Landers DV, Weisenfeld HC, Heine RP, Krohn MA, Hillier SL. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol. 2004;190:1004-10.
26. Spiegel SA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol. 1983;18:170-77.
27. Lewis JS, Kranig-Brown D, Trainor DA. DNA probe confirmatory test for Neisseria gonorrhosae. J Clin Microbiol. 1990;28:2349-50.
28. Schwebke JR, Zajackowski ME. Comparison of DNA probe (Gen-Probe) with culture for the detection of Neisseria gonorrhoeae in an urban STD programme. Genitourin Med. 1996;72:108-10.
29. Granato PA, Franz MR. Evaluation of a prototype DNA probe test for the noncultural diagnosis of gonorrhea. J Clin Microbiol. 1989;27: 632-5.
30. Szell A, Tisza T, Horvath A. A comparative study for detection of Chlamydia trachomatis and Neisseria gonorrhoeae with DNA probe. Acta Microbiol Immunol Hung. 1994;41:291-3.
31. Loeffelholz MJ, Lewinski CA, Silver SR, et al. Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J Clin Microbiol. 1992;30:2847-51.
32. Lees MI, Newman DM, Garland SM. Comparison of a DNA probe assay with culture for the detection of Chlamydia trachomatis. J Med Microbiol. 1991;35:159-61.
33. Mercer LJ, Robinson DC, Sahm DF, Lawrie MJ, Hajj SN. Comparison of chemiluminescent NA probe to cell culture for the screening of Chlamydia trachomatis in a gynecology clinic population. Obstet Gynecol. 1990;76:114-7.
34. U.S. Bureau of Labor Statistics. Employer Cost for Employee Compensation. Accessed December 2, 2003 (http://www.bls.gov/ncs/ect/home.htm#data).
35. Bloom BS, Wierz DJ, Pauly MV. Cost and price of comparable branded and generic pharmaceuticals. JAMA. 1986;256:2523-30.
36. 1993 Red Book. Montvale, NJ: Medical Economics Data Inc; 1993.
37. Edelson JT, Weinstein MC, Tosteson ANA, et al. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:407-13.
38. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med. 1986;302:1109-17.
39. Thibault GE. Diagnostic strategy-the shotgun versus the arrow. N Engl J Med. 1995;332:321-5.